Coordination of Germ Layer Lineage Choice by TET1 During Primed Pluripotency

Total Page:16

File Type:pdf, Size:1020Kb

Coordination of Germ Layer Lineage Choice by TET1 During Primed Pluripotency Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Coordination of germ layer lineage choice by TET1 during primed pluripotency Xinlong Luo,1 Bernard K. van der Veer,1 Lei Sun,1 Michela Bartoccetti,1 Matteo Boretto,2 Hugo Vankelecom,2 Rita Khoueiry,1,3 and Kian Peng Koh1 1Laboratory for Stem Cell and Developmental Epigenetics, 2Laboratory of Tissue Plasticity in Health and Disease, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium Gastrulation in the early postimplantation stage mammalian embryo begins when epiblast cells ingress to form the primitive streak or develop as the embryonic ectoderm. The DNA dioxygenase Tet1 is highly expressed in the epiblast and yet continues to regulate lineage specification during gastrulation when its expression is diminished. Here, we show how Tet1 plays a pivotal role upstream of germ layer lineage bifurcation. During the transition from naive pluripotency to lineage priming, a global reconfiguration redistributes Tet1 from Oct4-cobound promoters to distal regulatory elements at lineage differentiation genes, which are distinct from high-affinity sites engaged by Oct4. An altered chromatin landscape in Tet1-deficient primed epiblast-like cells is associated with enhanced Oct4 expression and binding to Nodal and Wnt target genes, resulting in collaborative signals that enhance mesendo- dermal and inhibit neuroectodermal gene expression during lineage segregation. A permissive role for Tet1 in neural fate induction involves Zic2-dependent engagement at neural target genes at lineage priming, is dependent on the signaling environment during gastrulation, and impacts neural tube closure after gastrulation. Our findings provide mechanistic information for epigenetic integration of pluripotency and signal-induced differentiation cues. [Keywords: epigenetics; pluripotency; developmental signaling; cell fate; germ layer segregation; chromatin accessibility] Supplemental material is available for this article. Received June 10, 2019; revised version accepted January 27, 2020. Embryonic development in mammals involves an early tence to differentiate in response to inductive signaling phase of gastrulation, when cell movements result in a cues at earlier stages of epiblast transitions (Smith 2017). massive reorganization of the embryo from a hollow The molecular mechanisms acting upstream of germ layer sphere of cells, or blastocyst, into a multilayered gastrula lineage decisions remain unclear. following implantation (Tam and Loebel 2007). The gas- The developmental progression of the epiblast through trula contains three germ layers known as ectoderm, me- lineage priming and germ layer fate allocation has been soderm, and endoderm that contain progenitors of all largely recapitulated in vitro using embryonic stem cell tissues in the adult body. In mice, the onset of gastrulation (ESC) cultures (Niwa 2010). Murine ESCs derived from occurs at embryonic day E6.5 with the appearance of a the preimplantation E3.5 blastocyst can be maintained primitive streak in the posterior region of the embryo, in a homogenous “ground state” with unrestricted “na- through which epiblast cells ingress by an epithelial- ive” pluripotency in chemically defined medium contain- mesenchymal transition to form progenitor cells of the ing leukemia inhibitory factor (LIF) and inhibitors of two mesoderm and definitive endoderm, also known as “mes- differentiation-inducing kinase pathways, commonly endoderm” (ME). Descendents of epiblast cells that do not known as 2iL (Ying et al. 2008). A 2-d differentiation pass through the primitive streak form the surface and protocol of 2iL-adapted ESCs to transient epiblast-like neural ectoderm (NE). These early lineages are specified cells (EpiLCs) in vitro captures the gastrulation-poised temporally and spatially through the coordinated activi- “primed” pluripotent state of the postimplantation epi- ties of various signaling pathways downstream from blast (Hayashi et al. 2011; Buecker et al. 2014). Earlier dif- wingless-related integrated site (Wnt), Nodal and bone ferentiation models utilizing murine ESCs relied on morphogenetic protein (BMP) family receptors (Robertson cellular aggregation in nonadherent conditions to form 2014; Muñoz-Descalzo et al. 2015; Zinski et al. 2018). embryoid bodies (EBs) containing germ layer progenitors However, recent studies suggest that cells acquire compe- © 2020 Luo et al. This article is distributed exclusively by Cold Spring 3Present address: Epigenetics Group, International Agency for Research on Harbor Laboratory Press for the first six months after the full-issue publi- Cancer, 69008 Lyon, France. cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After Corresponding author: [email protected] six months, it is available under a Creative Commons License (Attribu- Article published online ahead of print. Article and publication date are tion-NonCommercial 4.0 International), as described at http://creative- online at http://www.genesdev.org/cgi/doi/10.1101/gad.329474.119. commons.org/licenses/by-nc/4.0/. 598 GENES & DEVELOPMENT 34:598–618 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/20; www.genesdev.org Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Coordination of lineage choice by TET1 mimicking the gastrula (ten Berge et al. 2008). Under dif- sion of all three TET genes is low during gastrulation ferentiation-permissive conditions, a synergistic interde- (Khoueiry et al. 2017), suggesting that an epigenetic regu- pendency between canonical Wnt/β-catenin and Nodal latory mechanism allows TET1 to influence lineage segre- signaling pathways drives ME differentiation (Funa et al. gation even when expression is down-regulated. 2015; Wang et al. 2017). Further lineage specification de- Here, we ask how Tet1 controls developmental out- pends on modulation of collaborative signal inputs; strong comes by coordinating pluripotency and differentiation Nodal signals in EBs favor a definitive endoderm fate signals at entry points in the molecular circuitries of early while low levels or Wnt favor a mesoderm fate (Gadue embryonic lineage segregation. Our findings clarify how et al. 2006), in agreement with how graded Nodal morpho- Tet1 regulates the primed pluripotency epigenetic land- gen gradients in the primitive streak drive patterning of scape at the crossroads of ME and NE fate entry, providing definitive endoderm anteriorly and mesoderm posteriorly a cellular memory that regulates engagement of Oct4, in vivo (Vincent et al. 2003; Schier 2009; Robertson 2014). Wnt/β-catenin, and Nodal signaling effectors at develop- The use of cell culture mimics of early embryonic differ- mental loci during gastrulation. entiation has facilitated recent exploration of genomic regulatory mechanisms underlying early developmental cell state transitions. For example, the transitions from Results naive to primed pluripotency during conversion of 2iL Tet1 is repatterned to developmental fate loci during ESCs to EpiLCs have revealed global reorganization of pluripotency transition the master pluripotency transcription factor Oct4 at cell state-specific enhancer sites (Buecker et al. 2014). In hu- To examine whether Tet1 genomic occupancy changes man and murine ESCs, Oct4 co-occupies distal regulatory during the transition between naive and primed pluripo- elements with Smad2 and Smad3 (Smad2/3), closely relat- tency, we first performed Tet1 chromatin immunoprecip- ed downstream intracellular effectors of TGF-β/Activin/ itation sequencing (ChIP-seq) in ESCs cultured in 2iL Nodal receptors (Shi and Massagué 2003), to regulate tar- (naive state) and following in vitro conversion to EpiLCs get genes including Oct4 (also known as Pou5f1), Nodal, (primed state). Based on differential binding intensities and its antagonist, Lefty1 (Mullen et al. 2011), in an auto- determined from biological replicates (n = 2) of wild-type regulatory feedback loop. Upon exit from pluripotency, (WT) cells and normalized to Tet1-deficient (knockout Oct4 continues to determine germ layer fate selection [KO]) negative controls (Supplemental Fig. S1A), we by promoting ME and repressing NE fate (Thomson defined Tet1-bound peaks preferentially enriched in et al. 2011), through new cooperative interactions with 2iL-treated ESCs (ESC-specific, 1256) or EpiLCs (EpiLC- tissue-specific and signal-dependent factors at lineage- specific, 5557) and those where Tet1 binding did not priming genomic sites (Funa et al. 2015; Simandi et al. show significant differences between the two states (com- 2016). Collectively, these studies suggest that the capacity mon, 5741) (Fig. 1A; Supplemental Table S1). The sizable of transcription factors (TFs) to access enhancer sites to numbers of EpiLC-specific binding peaks suggest the pres- drive cell fate choice is highly context-dependent. The ence of de novo Tet1 binding, in line with detection of complex circuitry that decides which factor(s) dominates EpiLC-specific and Tet1-dependent differentially hydrox- in the process of ESC commitment to ME or NE fate, ymethylated regions previously observed during ESC-to- whether stochastic or predetermined by regulators acting EpiLC differentiation (Khoueiry et al. 2017). Moreover, upstream of lineage bifurcation, remains to be worked out even though Tet1 binding profiles were preferentially en- in further detail. riched at gene promoter
Recommended publications
  • Ncomms2254.Pdf
    ARTICLE Received 3 May 2012 | Accepted 5 Nov 2012 | Published 4 Dec 2012 DOI: 10.1038/ncomms2254 The RB family is required for the self-renewal and survival of human embryonic stem cells Jamie F. Conklin1,2,3, Julie Baker2,3 & Julien Sage1,2,3 The mechanisms ensuring the long-term self-renewal of human embryonic stem cells are still only partly understood, limiting their use in cellular therapies. Here we found that increased activity of the RB cell cycle inhibitor in human embryonic stem cells induces cell cycle arrest, differentiation and cell death. Conversely, inactivation of the entire RB family (RB, p107 and p130) in human embryonic stem cells triggers G2/M arrest and cell death through functional activation of the p53 pathway and the cell cycle inhibitor p21. Differences in E2F target gene activation upon loss of RB family function between human embryonic stem cells, mouse embryonic stem cells and human fibroblasts underscore key differences in the cell cycle regulatory networks of human embryonic stem cells. Finally, loss of RB family function pro- motes genomic instability in both human and mouse embryonic stem cells, uncoupling cell cycle defects from chromosomal instability. These experiments indicate that a homeostatic level of RB activity is essential for the self-renewal and the survival of human embryonic stem cells. 1 Department of Pediatrics, Stanford Medical School, Stanford, California 94305, USA. 2 Department of Genetics, Stanford Medical School, Stanford, California 94305, USA. 3 Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medical School, Stanford, California 94305, USA. Correspondence and requests for materials should be addressed to J.S.
    [Show full text]
  • Author Manuscript Faculty of Biology and Medicine Publication
    Serveur Académique Lausannois SERVAL serval.unil.ch Author Manuscript Faculty of Biology and Medicine Publication This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Published in final edited form as: Title: Sexual dimorphism in cancer. Authors: Clocchiatti A, Cora E, Zhang Y, Dotto GP Journal: Nature reviews. Cancer Year: 2016 May Volume: 16 Issue: 5 Pages: 330-9 DOI: 10.1038/nrc.2016.30 In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. Sexual dimorphism in cancer Andrea Clocchiatti1+, Elisa Cora2+, Yosra Zhang1,2 and G. Paolo Dotto1,2* 1Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; 2Department of Biochemistry, University of Lausanne, Epalinges, CH-1066, Switzerland + These authors contributed equally to the work * Corresponding author: G. Paolo Dotto email: [email protected] 1 Abstract The incidence of many cancer types is significantly higher in the male than female populations, with associated differences in survival. Occupational and/or behavioral factors are well known underlying determinants. However, cellular/molecular differences between the two sexes are also likely to be important. We are focusing here on the complex interplay that sexual hormones and sex chromosomes can have in intrinsic control of cancer initiating cell populations, tumor microenvironment and systemic determinants of cancer development like the immune system and metabolism. A better appreciation of these differences between the two sexes could be of substantial value for cancer prevention as well as treatment.
    [Show full text]
  • Human Autologous Ipsc–Derived Dopaminergic Progenitors Restore Motor Function in Parkinson’S Disease Models
    Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models Bin Song, … , Jeffrey S. Schweitzer, Kwang-Soo Kim J Clin Invest. 2020;130(2):904-920. https://doi.org/10.1172/JCI130767. Research Article Neuroscience Stem cells Graphical abstract Find the latest version: https://jci.me/130767/pdf RESEARCH ARTICLE The Journal of Clinical Investigation Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models Bin Song,1,2 Young Cha,1,2 Sanghyeok Ko,1,2 Jeha Jeon,1,2 Nayeon Lee,1,2 Hyemyung Seo,1,2,3 Kyung-Joon Park,1 In-Hee Lee,4,5 Claudia Lopes,1,2 Melissa Feitosa,1,2 María José Luna,1,2 Jin Hyuk Jung,1,2 Jisun Kim,1,2,3 Dabin Hwang,1,2 Bruce M. Cohen,1 Martin H. Teicher,1 Pierre Leblanc,1,2 Bob S. Carter,6 Jeffrey H. Kordower,7 Vadim Y. Bolshakov,1 Sek Won Kong,4,5 Jeffrey S. Schweitzer,6 and Kwang-Soo Kim1,2 1Department of Psychiatry and 2Molecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA. 3Department of Molecular and Life Sciences, Hanyang University, Ansan, Korea. 4Department of Pediatrics, 5Computational Health Informatics Program, Boston Children’s Hospital, and 6Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. 7Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. Parkinson’s disease (PD) is a neurodegenerative disorder associated with loss of striatal dopamine, secondary to degeneration of midbrain dopamine (mDA) neurons in the substantia nigra, rendering cell transplantation a promising therapeutic strategy.
    [Show full text]
  • Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Co-Regulator in Invasive 6 Lobular Carcinoma of the Breast 7 8 Evelyn K
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.16.423142; this version posted December 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Running Title: MDC1 co-regulates ER in ILC 2 3 Research article 4 5 Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive 6 lobular carcinoma of the breast 7 8 Evelyn K. Bordeaux1+, Joseph L. Sottnik1+, Sanjana Mehrotra1, Sarah E. Ferrara2, Andrew E. Goodspeed2,3, James 9 C. Costello2,3, Matthew J. Sikora1 10 11 +EKB and JLS contributed equally to this project. 12 13 Affiliations 14 1Dept. of Pathology, University of Colorado Anschutz Medical Campus 15 2Biostatistics and Bioinformatics Shared Resource, University of Colorado Comprehensive Cancer Center 16 3Dept. of Pharmacology, University of Colorado Anschutz Medical Campus 17 18 Corresponding author 19 Matthew J. Sikora, PhD.; Mail Stop 8104, Research Complex 1 South, Room 5117, 12801 E. 17th Ave.; Aurora, 20 CO 80045. Tel: (303)724-4301; Fax: (303)724-3712; email: [email protected]. Twitter: 21 @mjsikora 22 23 Authors' contributions 24 MJS conceived of the project. MJS, EKB, and JLS designed and performed experiments. JLS developed models 25 for the project. EKB, JLS, SM, and AEG contributed to data analysis and interpretation. SEF, AEG, and JCC 26 developed and performed informatics analyses. MJS wrote the draft manuscript; all authors read and revised the 27 manuscript and have read and approved of this version of the manuscript.
    [Show full text]
  • UTX Regulates Mesoderm Differentiation of Embryonic Stem Cells Independent of H3K27 Demethylase Activity
    UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity Chaochen Wanga, Ji-Eun Leea,1, Young-Wook Chob,1, Ying Xiaoc, Qihuang Jina, Chengyu Liud, and Kai Gea,2 aLaboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; bKorea Basic Science Institute Chuncheon Center, Chuncheon, Kangwon, Korea 200-701; cDermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and dTransgenic Core, Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 Edited by Mark Groudine, Fred Hutchinson Cancer Research Center, Seattle, WA, and approved August 3, 2012 (received for review March 9, 2012) To investigate the role of histone H3K27 demethylase UTX in male cells. UTY is a paralog of the X-linked UTX and shares embryonic stem (ES) cell differentiation, we have generated UTX 88% sequence homology with UTX protein. Unlike UTX, UTY knockout (KO) and enzyme-dead knock-in male ES cells. Deletion lacks detectable histone demethlase activity in vitro (8, 12). The of the X-chromosome-encoded UTX gene in male ES cells markedly viability data from male and female UTX KO mice indicate a decreases expression of the paralogous UTY gene encoded by Y largely functional redundancy between UTX and UTY during chromosome, but has no effect on global H3K27me3 level, Hox male embryonic development (13). gene expression, or ES cell self-renewal. However, UTX KO cells UTX has been shown to regulate myocyte differentiation, heart show severe defects in mesoderm differentiation and induction of development, and T-box transcription factor target gene expres- Brachyury, a transcription factor essential for mesoderm develop- sion (13–15).
    [Show full text]
  • Cell Reprogramming Technologies for Treatment And
    CELL REPROGRAMMING TECHNOLOGIES FOR TREATMENT AND UNDERSTANDING OF GENETIC DISORDERS OF MYELIN by ANGELA MARIE LAGER Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Thesis advisor: Paul J Tesar, PhD Department of Genetics and Genome Sciences CASE WESTERN RESERVE UNIVERSITY May 2015 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Angela Marie Lager Candidate for the Doctor of Philosophy degree*. (signed) Ronald A Conlon, PhD (Committee Chair) Paul J Tesar, PhD (Advisor) Craig A Hodges, PhD Warren J Alilain, PhD (date) 31 March 2015 *We also certify that written approval has been obtained from any proprietary material contained therein. TABLE OF CONTENTS Table of Contents……………………………………………………………………….1 List of Figures……………………………………………………………………………4 Acknowledgements……………………………………………………………………..7 Abstract…………………………………………………………………………………..8 Chapter 1: Introduction and Background………………………………………..11 1.1 Overview of mammalian oligodendrocyte development in the spinal cord and myelination of the central nervous system…………………..11 1.1.1 Introduction……………………………………………………..11 1.1.2 The establishment of the neuroectoderm and ventral formation of the neural tube…………………………………..12 1.1.3 Ventral patterning of the neural tube and specification of the pMN domain in the spinal cord……………………………….15 1.1.4 Oligodendrocyte progenitor cell production through the process of gliogenesis ………………………………………..16 1.1.5 Oligodendrocyte progenitor cell to oligodendrocyte differentiation…………………………………………………...22
    [Show full text]
  • Regulation of Adult Neurogenesis in Mammalian Brain
    International Journal of Molecular Sciences Review Regulation of Adult Neurogenesis in Mammalian Brain 1,2, 3, 3,4 Maria Victoria Niklison-Chirou y, Massimiliano Agostini y, Ivano Amelio and Gerry Melino 3,* 1 Centre for Therapeutic Innovation (CTI-Bath), Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK; [email protected] 2 Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK 3 Department of Experimental Medicine, TOR, University of Rome “Tor Vergata”, 00133 Rome, Italy; [email protected] (M.A.); [email protected] (I.A.) 4 School of Life Sciences, University of Nottingham, Nottingham NG7 2HU, UK * Correspondence: [email protected] These authors contributed equally to this work. y Received: 18 May 2020; Accepted: 7 July 2020; Published: 9 July 2020 Abstract: Adult neurogenesis is a multistage process by which neurons are generated and integrated into existing neuronal circuits. In the adult brain, neurogenesis is mainly localized in two specialized niches, the subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) adjacent to the lateral ventricles. Neurogenesis plays a fundamental role in postnatal brain, where it is required for neuronal plasticity. Moreover, perturbation of adult neurogenesis contributes to several human diseases, including cognitive impairment and neurodegenerative diseases. The interplay between extrinsic and intrinsic factors is fundamental in regulating neurogenesis. Over the past decades, several studies on intrinsic pathways, including transcription factors, have highlighted their fundamental role in regulating every stage of neurogenesis. However, it is likely that transcriptional regulation is part of a more sophisticated regulatory network, which includes epigenetic modifications, non-coding RNAs and metabolic pathways.
    [Show full text]
  • Abbit Monoclonal Igg Antibody Against Human, Mouse SOX1
    Anti-Human SOX1 Antibody, Clone EPR4766 Antibodies Rabbit monoclonal IgG antibody against human, mouse SOX1 Catalog #60095 0.1 mL Product Description The EPR4766 antibody reacts with SOX1, also known as SRY (sex determining region Y)-box 1, an ~40 kDa nuclear transcription factor belonging to the SRY-related HMG-box family. SOX1 is involved in regulating development of the central nervous system and is an early marker for neuroectodermal differentiation in the embryo. Its expression is down-regulated during differentiation in many neuronal subtypes. SOX1 is also a useful marker for identifying embryonic and somatic neuronal progenitor cells (NPCs), in concert with other markers such as SOX2 and SOX9. SOX1 is thought to promote self-renewal in NPCs, whereas it functions in other cell types to promote differentiation. There is evidence that SOX1 plays a role in tumor suppression by binding to ß-catenin and attenuating the WNT signaling pathway, and in mice it plays an essential role in lens development by regulating expression of γ-crystallins. The EPR4766 antibody does not cross-react with rat SOX1. Target Antigen Name: SOX1 Alternative Names: Sox-1, SRY (sex determining region Y)-box 1, SRY-related HMG-box Gene ID: 6656 Species Reactivity: Human, Mouse Host Species: Rabbit Clonality: Monoclonal Clone: EPR4766 Isotype: IgG Immunogen: Synthetic peptide corresponding to the partial amino acid sequence of human SOX1 Conjugate: Unconjugated Applications Verified: ICC, IF, IHC, WB Reported: ICC, IF, IHC, WB Special Applications: This antibody clone has been verified for labeling neural stem and progenitor cells grown with STEMdiff™ Neural Induction Medium (Catalog #05835), STEMdiff™ Neural Progenitor Medium (Catalog #05833), NeuroCult™ NS-A Proliferation Kit (Human; Catalog #05751) and NeuroCult™ Proliferation Kit (Mouse; Catalog #05702).
    [Show full text]
  • Speaker Abstracts 2018 International Chordoma Research Workshop | Speaker Abstracts 1
    Sixth International Chordoma Research Workshop Speaker abstracts 2018 International Chordoma Research Workshop | Speaker abstracts 1 TABLE OF CONTENTS EPIGENETIC CONTROL OF BRACHYURY AND METABOLIC STRESS RESPONSE: NOVEL THERAPEUTIC TARGETS FOR CHORDOMA ........................................................................................................................................................... 2 SYSTEMATIC DISCOVERY OF NOVEL VULNERABILITIES IN CHORDOMA .................................................................. 3 RATIONALE FOR THE ADVANCEMENT OF PTEN/AKT PATHWAY INHIBITORS AND COMBINATIONS FOR PERSONALIZED CHORDOMA THERAPY ................................................................................................................... 4 THE ROLE OF PHILANTHROPY IN TRANSFORMING CANCER RESEARCH .................................................................. 5 BRACHYURY IN CHORDOMA AND CARCINOMAS: BIOLOGY AND POTENTIAL TARGETING APPROACHES ............... 6 CHARTING BRACHYURY-MEDIATED DEVELOPMENTAL PATHWAYS DURING EARLY MOUSE EMBRYOGENESIS ...... 7 CRYSTAL STRUCTURES OF BRACHYURY: A PRELUDE TO DRUG DISCOVERY ............................................................ 8 A BRACHYURY TRANSCRIPTIONAL REPORTER TO GUIDE DRUG DISCOVERY........................................................... 9 INVESTIGATING BRACHYURY GENE REGULATION TO IDENTIFY THERAPEUTIC TARGETS IN CHORDOMA ............. 10 DELINEATING AND TARGETING THE BRACHYURY-YAP REGULATORY AXIS IN CANCER ......................................... 11 OPEN ACCESS
    [Show full text]
  • Bangor University DOCTOR of PHILOSOPHY Brachyury in the Human Colon and Colorectal Cancer Williams, Jason
    Bangor University DOCTOR OF PHILOSOPHY Brachyury in the Human Colon and Colorectal Cancer Williams, Jason Award date: 2018 Awarding institution: Bangor University Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 04. Oct. 2021 Brachyury in the Human Colon and Colorectal Cancer Ph. D. Thesis 2017 Jason Saunders Williams i Declaration and Consent Details of the Work I hereby agree to deposit the following item in the digital repository maintained by Bangor University and/or in any other repository authorized for use by Bangor University. Author Name: Title: Supervisor/Department: Funding body (if any): Qualification/Degree obtained: PhD This item is a product of my own research endeavours and is covered by the agreement below in which the item is referred to as “the Work”. It is identical in content to that deposited in the Library, subject to point 4 below.
    [Show full text]
  • Onecut Transcription Factor OC2 Is a Direct Target of T-Bet in Type-1 T-Helper Cells
    Genes and Immunity (2008) 9, 302–308 & 2008 Nature Publishing Group All rights reserved 1466-4879/08 $30.00 www.nature.com/gene ORIGINAL ARTICLE Onecut transcription factor OC2 is a direct target of T-bet in type-1 T-helper cells K Furuno1,2, K Ikeda2, S Hamano3, K Fukuyama1, M Sonoda1, T Hara2, T Sasazuki4 and K Yamamoto1 1Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; 2Department of Pediatrics, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan; 3Department of Parasitology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan and 4International Medical Center of Japan, Tokyo, Japan T-box transcription factor, T-bet, has a central role in the differentiation of T-helper (Th) progenitor cells to Th1 or Th2 effector cells, partly by regulating the expression of genes such as interferon-g (IFN-g). However, the direct target genes, especially those mediating the transcriptional network initiated by T-bet, are not yet fully understood. By combining chromatin immunoprecipitation from Th1 cells with human cytosine-phosphate-guanine-island array analysis, Onecut 2 (OC2), which encodes a member of the ONECUT class of transcriptional activators, was identified as a direct target gene of T-bet. OC2 is expressed in Th1 but not Th2 cells and reporter assays showed that T-bet transactivates OC2 transcription through putative T-bet half-sites locating À451 to À347 of OC2 promoter region. Moreover, we found that OC2 binds and transactivates human T-bet promoter. These results suggest that not only cell-extrinsic regulation via the IFN-g/STAT1 pathway, but also cell-intrinsic transcriptional positive feedback loop between T-bet and OC2 could be involved in Th1 development.
    [Show full text]
  • Expression of a SOX1 Overlapping Transcript in Neural Differentiation and Cancer Models
    Cell. Mol. Life Sci. DOI 10.1007/s00018-017-2580-3 Cellular and Molecular Life Sciences ORIGINAL ARTICLE Expression of a SOX1 overlapping transcript in neural differentiation and cancer models 1 1 2 1 Azaz Ahmad • Stephanie Strohbuecker • Cristina Tufarelli • Virginie Sottile Received: 28 January 2017 / Revised: 4 June 2017 / Accepted: 26 June 2017 Ó The Author(s) 2017. This article is an open access publication ABSTRACT SOX1 is a member of the SOXB1 subgroup expression of SOX1 and SOX1-OT was further observed in of transcription factors involved in early embryogenesis, several cancer cell models. While the function of this CNS development and maintenance of neural stem cells. transcript is unknown, the regulatory role reported for other The structure and regulation of the human SOX1 locus has lncRNAs strongly suggests a possible role for SOX1-OT in been less studied than that of SOX2, another member of the regulating SOX1 expression, as previously observed for SOXB1 subgroup for which an overlapping transcript has SOX2. The elucidation of the genetic and regulatory con- been reported. Here we report that the SOX1 locus harbours text governing SOX1 expression will contribute to a SOX1 overlapping transcript (SOX1-OT), and describe clarifying its role in stem cell differentiation and expression, splicing variants and detection of SOX1-OT in tumorigenesis. different stem and cancer cells. RT-PCR and RACE experiments were performed to detect and characterise the Keywords Stem cell Á LncRNA Á SOX1-OT Á structure of SOX1-OT in neuroprogenitor cultures and Expression pattern Á Cancer model Á SOX1 across different cancer cell lines.
    [Show full text]